ASCO 2020: Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS
The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol…
Browsing: HER2-positive DCIS
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- The OJC Episode 26: IASLC World Conference on Lung Cancer Part 2
- Mutant gene-targeted immunotherapy approach developed
- Genomic Data Commons provides unprecedented cancer data resource
- Researchers watch anti-cancer drug release from DNA nanostructures in real time
- Lab profiles histone mutational landscape of human cancers
- Unburdening China of cancer: trend analysis to assist prevention measures
- Single cell sequencing opens new avenues for eradicating leukaemia at its source
- Lung cancer cells have differential signalling responses to KRAS inhibitor treatment
